Healthcare · Biotechnology · NASDAQ
| Market cap | $11.38B |
|---|---|
| Trailing P/E | 37.6 |
| FCF yield | 2.3% |
| Revenue growth (YoY) | -0.4% |
| EPS growth (YoY) | +0.0% |
| FCF/share growth (YoY) | +4.4% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
Bio-Techne Corporation trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| April McClain Delaney | House | Sell | $1,001 - $15,000 | May 6, 2026 |
| April McClain Delaney | House | Sell | $1,001 - $15,000 | Apr 6, 2026 |
| April McClain Delaney | House | Sell | $1,001 - $15,000 | Mar 10, 2026 |
| April McClain Delaney | House | Sell | $1,001 - $15,000 | Feb 2, 2026 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | Jan 5, 2026 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | Jan 5, 2026 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | Nov 4, 2025 |
| April McClain Delaney | House | Sell | $1,001 - $15,000 | Sep 2, 2025 |
| April McClain Delaney | House | Sell | $1,001 - $15,000 | Jul 2, 2025 |
| Julie Johnson | House | Sell | $1,001 - $15,000 | May 14, 2025 |
| Rob Bresnahan | House | Sell | $1,001 - $15,000 | May 8, 2025 |
| April McClain Delaney | House | Buy | $1,001 - $15,000 | May 2, 2025 |